EverSource Wealth Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94K | Buy |
5,429
+4,191
| +339% | +$72.5K | ﹤0.01% | 1233 |
|
|
2025
Q1 | $27.1K | Buy |
1,238
+452
| +58% | +$9.89K | ﹤0.01% | 1529 |
|
|
2024
Q4 | $25.1K | Buy |
786
+758
| +2,707% | +$24.2K | ﹤0.01% | 1506 |
|
|
2024
Q3 | $808 | Sell |
28
-6
| -18% | -$173 | ﹤0.01% | 2766 |
|
|
2024
Q2 | $1.35K | Sell |
34
-5
| -13% | -$198 | ﹤0.01% | 2662 |
|
|
2024
Q1 | $1.72K | Buy |
39
+11
| +39% | +$486 | ﹤0.01% | 2431 |
|
|
2023
Q4 | $1.68K | Hold |
28
| – | – | ﹤0.01% | 2225 |
|
|
2023
Q3 | $1.07K | Buy |
28
+22
| +367% | +$837 | ﹤0.01% | 2177 |
|
|
2023
Q2 | $547 | Buy |
+6
| New | +$547 | ﹤0.01% | 2331 |
|